Updated Date: Wed, 15 Apr 2020 00:00:00 EDT

Antimalarial hydroxychloroquine has raked in support as a potential wonder drug to treat COVID-19, with even President Donald […]

Novartis and Incyte’s Jakafi has had a whirlwind few weeks as it rolls into a late-stage trial as […]

Like many people around the world just now, those living in the São Paulo neighbourhood of Paraisópolis are […]

“Deep breath in … and out. Again, deep breath in … and out.”We tune in to patients’ breath […]

The European Medicines Agency’s pharmacovigilance risk assessment committee (PRAC) has recommended updating the product information for drugs containing […]

The recent publication of an industry sponsored, open, non-randomised study of remdesivir in a heterogeneous patient population has […]

An inquiry into childbirth cases of “serious and potentially serious concern” at Shrewsbury and Telford Hospitals NHS Trust […]

With a major Indian production hub now locked down in a COVID-19 containment zone, the spotlight on pharma’s […]

SVBLeerink analysts had expected sales of Pfizer’s hot new drug Vyndaqel to treat ATTR cardiomyopathy to come in […]